<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03917186</url>
  </required_header>
  <id_info>
    <org_study_id>DESEVAR</org_study_id>
    <nct_id>NCT03917186</nct_id>
  </id_info>
  <brief_title>Desflurane vs. Sevoflurane in Endovascular Aortic Repair</brief_title>
  <official_title>Fast-track in Endovascular Aortic Aneurysm Repair With Desflurane and Sevoflurane: a Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Begoña Quintana Villamandos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Baxter Healthcare Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital General Universitario Gregorio Marañon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized Clinical Trial following the evaluation of the impact on renal function in
      patients undergoing endovascular aortic aneurysm repair with two anesthetics protocols
      (Desflurane versus Sevoflurane) on the first 24 hours after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Randomized Clinical Trial to evaluate the impact on renal function in patients undergoing
      endovascular aortic aneurysm repair with two anesthetics protocols (Desflurane versus
      Sevoflurane) on the first 24 hours after surgery.

      Secondary Endpoint: Among secondary endpoints we will evaluate clinical variables such
      emergence and recovery characteristics (time to extubation and time to emergence-open eyes
      and response to verbal command), the need for postoperative mechanical ventilation, the
      post-anesthesia recovery score and ICU length of stay.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 20, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>All these parameters will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>NGAL in urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>Cystatin C(mg/L) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>Creatinine(mg/dL) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>sodium(mMol/L) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>potassium(mMol/L) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>Chloride(mMol/L) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>albumin(g/dL) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>osmolarity(mOsm/Kg) in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>NGAL in plasma</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>Creatinine(mg/dL) in urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>sodium(mMol/L) in urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>potassium(mMol/L) in urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>Chloride(mMol/L) in urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>albumin(g/dL) in urine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Biochemical parameters</measure>
    <time_frame>will be evaluated at baseline (presurgery), at the end surgery and 24 hours after surgery in both study groups</time_frame>
    <description>osmolarity(mOsm/Kg) in urine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for postoperative mechanical ventilation</measure>
    <time_frame>24 hours</time_frame>
    <description>hours of mechanical ventilation in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>hours in ICU</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anesthetic recovery</measure>
    <time_frame>These variable will be recorded immediately after surgery (from anesthetics discontinuation). The postanesthesia recovery score before will be recorded at baseline and after surgery. time frame upto 1 hour(stimated)</time_frame>
    <description>time to extubation(minutes).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anesthetic recovery</measure>
    <time_frame>These variable will be recorded immediately after surgery (from anesthetics discontinuation). The postanesthesia recovery score before will be recorded after surgery. timeframe up to 1 hour(stimated).</time_frame>
    <description>time to spontaneous eye opening(minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anesthetic recovery</measure>
    <time_frame>These variable will be recorded immediately after surgery (from anesthetics discontinuation). The postanesthesia recovery score before will be recorded after surgery. timeframe up to 1 hour(stimated).</time_frame>
    <description>time until first response to verbal commands(minutes)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>anesthetic recovery</measure>
    <time_frame>These variable will be recorded immediately after surgery (from anesthetics discontinuation). The postanesthesia recovery score before will be recorded at baseline and after surgery. timeframe 1 hour(stimated)</time_frame>
    <description>The post-anesthesia recovery score ( Modified Aldrete score) (0-1-2 from worse to better)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Renal Failure</condition>
  <arm_group>
    <arm_group_label>Group sevoflurane</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Administration under labelling conditions</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group desflurane</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Administration under labelling conditions</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sevoflurane</intervention_name>
    <description>administration of sevoflurane</description>
    <arm_group_label>Group sevoflurane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Desflurane</intervention_name>
    <description>administration of Desflurane</description>
    <arm_group_label>Group desflurane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  older than 18 years undergoing elective endovascular aortic repair

          -  who have signed informed consent

        Exclusion Criteria:

          -  urgent surgery

          -  with known hypersensitivity to Desflurane or Sevoflurane.

          -  Renal failure in hemodialysis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Begoña Quintana, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General Universitario Gregorio Marañón</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Begoña Quintana, PhD</last_name>
    <phone>+34649265601</phone>
    <email>begoquinti@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital general universitario Gregorio Marañón</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>BEGOÑA QUINTANA, PhD</last_name>
      <phone>34649265601</phone>
      <email>begoquinti@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>September 25, 2017</study_first_submitted>
  <study_first_submitted_qc>April 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>April 12, 2019</last_update_submitted>
  <last_update_submitted_qc>April 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Hospital General Universitario Gregorio Marañon</investigator_affiliation>
    <investigator_full_name>Begoña Quintana Villamandos</investigator_full_name>
    <investigator_title>Anesthesiologsit</investigator_title>
  </responsible_party>
  <keyword>Desflurane, Sevoflurane, Endovascular aortic repair</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sevoflurane</mesh_term>
    <mesh_term>Desflurane</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

